Original Article

Relationship between Tumor Necrosis Factor-Alpha and Neuropeptide Y Expression and Neurological Function Score in Epileptic Children

Abstract

Background: To observe the relationship between Tumor Necrosis Factor-alpha (TNF-α) and Neuropeptide Y (NPY) expression and neurological function score in epileptic children.

Methods: Fifty-four epileptic children diagnosed and treated in Xuzhou Children's Hospital, China from Feb 2017 to Mar 2018 were collected and included in a research group (RG), while 30 healthy children who underwent physical examination at the same time were included in the control group (CG). ELISA was used to detect the expression of TNF-α and NPY in the serum of children in the two groups, and those before treatment were compared. The National Institute of Health stroke scale (NIHSS) and Hamilton Anxiety (HAMA) scores before and after treatment were observed, and Pearson correlation was used to analyze the relationship between the expression levels of TNF-α and NPY in the serum as well as NIHSS and HAMA scores.

Results: The expression levels of TNF-α and NPY in the serum of children in the RG were significantly higher than those in the CG (P<0.001). The expression level of TNF-α was positively correlated with the NIHSS and HAMA scores (r=0.748, P<0.001) (r=0.772, P<0.001). The expression level of NPY was positively correlated with the NIHSS and HAMA scores (r=0.768, P<0.001) (r=0.643, P<0.001).

Conclusion: TNF-α and NPY are highly expressed in epileptic children and are positively correlated with neurological function score.

1. Fisher RS, Acevedo C, Arzimanoglou A, et al (2014). ILAE official report: a practical clinical de finition of epilepsy. Epilepsia, 55(4): 475-482.
2. Newton CR, Garcia HH (2012). Epilepsy in poor regions of the world. Lancet, 380(9848): 1193-1201.
3. Ngugi AK, Bottomley C, Kleinschmidt I, et al (2010). Estimation of the burden of ac-tive and life‐time epilepsy: a meta‐analytic approach. Epilepsia, 51(5): 883-890.
4. Ngugi AK, Kariuki SM, Bottomley C, et al (2011). Incidence of epilepsy: a systematic review and meta‐analysis. Neurology, 77(10): 1005-1012.
5. Mbuba CK, Ngugi AK, Newton CR, et al (2008). The epilepsy treatment gap in de-veloping countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia, 49(9): 1491-1503.
6. Banerjee TK, Ray BK, Das SK, et al (2010). A longitudinal study of epilepsy in Kolka-ta, India. Epilepsia, 51(12): 2384-2391.
7. Meyer AC, Dua T, Ma J, et al (2010). Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Organ, 88(4): 260-266.
8. Camfield P, Camfield C (2015). Incidence, prevalence and aetiology of seizures and epilepsy in children. Epileptic Disord, 17(2): 117-123.
9. Aaberg KM, Gunnes N, Bakken IJ, et al (2017). Incidence and prevalence of childhood epilepsy: a nationwide cohort study. Pediatrics, 139(5): e20163908.
10. Thurman DJ, Logroscino G, Beghi E, et al (2017). The burden of premature mortali-ty of epilepsy in high‐income countries: a systematic review from the Mortality Task Force of the International League against Epilepsy. Epilepsia, 58(1): 17-26.
11. Koh HK, Kobau R, Whittemore VH, et al (2014). Toward an integrated public health approach for epilepsy in the 21st century. Prev Chronic Dis, 11: E146.
12. Institute of Medicine (2012). Epilepsy across the spectrum: promoting health and un-derstanding. Washington (DC): National Academies Press (US).
13. Kokaia M (2016). Combinatorial gene thera-py for epilepsy: simultaneous NPY and Y2 overexpression. Neuropeptides, 55: 4-5.
14. Li C, Wu X, Liu S, et al (2019). Roles of neu-ropeptide Y in neurodegenerative and neuroimmune diseases. Front Neurosci, 13: 869.
15. Ferreira R, Xapelli S, Santos T, et al (2010). Neuropeptide Y modulation of interleu-kin-1{beta} (IL-1{beta})-induced nitric oxide production in microglia. J Biol Chem, 285(53): 41921-41934.
16. Li Q, Dong C, Li W, et al (2014). Neuro-peptide Y protects cerebral cortical neu-rons by regulating microglial immune function. Neural Regen Res, 9(9): 959-967.
17. Han K, Wang QY, Wang CX, et al (2018). Ghrelin improves pilocarpine induced cerebral cortex inflammation in epileptic rats by inhibiting NF κB and TNF α. Mol Med Rep, 18(4): 3563-3568.
18. Berg AT, Berkovic SF, Brodie MJ, et al (2010). Revised terminology and concepts for organization of seizures and epilep-sies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia, 51(4): 676-685.
19. Ortiz GA, Ralph LS (2014). National insti-tutes of health stroke scale (nihss). Wiley Stats Ref: Statistics Reference Online.
20. Thompson E (2015). Hamilton rating scale for anxiety (HAM-A). Occup Med (Lond), 65(7): 601.
21. Hamiwka LD, Singh N, Niosi J, et al (2007). Diagnostic inaccuracy in children referred with “first seizure”: role for a first seizure clinic. Epilepsia, 48(6): 1062-1066.
22. Chowdhury FA, Nashef L, Elwes RDC (2008). Misdiagnosis in epilepsy: a review and recognition of diagnostic uncertainty. Eur J Neurol, 15(10): 1034-1042.
23. Aaberg KM, Bakken IJ, Lossius MI, et al (2016). Comorbidity and childhood epi-lepsy: a nationwide registry study. Pediat-rics, 138(3): e20160921.
24. Patrício MI, Barnard AR, Green AL, et al (2018). A clinical-grade gene therapy vec-tor for pharmacoresistant epilepsy suc-cessfully overexpresses NPY in a human neuronal cell line. Seizure, 55: 25-29.
25. Li TR, Jia YJ, Wang Q, et al (2018). Correla-tion between tumor necrosis factor alpha mRNA and microRNA-155 expression in rat models and patients with temporal lobe epilepsy. Brain Res, 1700: 56-65.
26. Botterill JJ, Guskjolen AJ, Marks WN, et al (2015). Limbic but not non-limbic kin-dling impairs conditioned fear and pro-motes plasticity of NPY and its Y2 recep-tor. Brain Struct Funct, 220(6): 3641-3655.
27. Oztas B, Sahin D, Kir H, et al (2017). The effect of leptin, ghrelin, and neuropep-tide-Y on serum Tnf-Α, Il-1β, Il-6, Fgf-2, galanin levels and oxidative stress in an experimental generalized convulsive sei-zure model. Neuropeptides, 61: 31-37.
28. Janigro D, Iffland PH 2nd, Marchi N, et al (2013). A role for inflammation in status epilepticus is revealed by a review of cur-rent therapeutic approaches. Epilepsia, 54 Suppl 6 (06): 30-32.
29. Li Q, Cao W, Liao X, et al (2015). Altered resting state functional network connec-tivity in children absence epilepsy. J Neurol Sci, 354(1-2): 79-85.
Files
IssueVol 50 No 5 (2021) QRcode
SectionOriginal Article(s)
Published2021-04-30
DOI https://doi.org/10.18502/ijph.v50i5.6123
Keywords
Tumor necrosis factor-alpha Neuropeptide Y; Epileptic children Neurological function

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Qiu L, Zhang D, Sang Y, Zheng N, Chen J, Qiu X, Liu X. Relationship between Tumor Necrosis Factor-Alpha and Neuropeptide Y Expression and Neurological Function Score in Epileptic Children. Iran J Public Health. 50(5):1056-1064.